IDF has expanded its CHiKPRO® portfolio to include CHiKPRO® Collagen Bone Broth, an ingredient that recently received a patent for collagen content and significant prebiotic effect in preclinical research trials. IDF exhibited the ingredient to the industry at the October 2019 SupplySide West trade show in Las Vegas.
CHiKPRO® Collagen is made from chicken bone broth that has been enriched for type II collagen, guaranteeing a 55 percent minimum level of collagen. The United States Patent Office granted a patent based, in part on the results of two preclinical studies from the Center for Biomedical & Life Sciences at Missouri State University. The trials demonstrated a significant prebiotic effect of increasing Lactobacillus and which poses opportunity to reduce and/or eliminate the need for regular probiotic supplements. The studies also showed that CHiKPRO® Collagen can reduce COX-2 activity by at least 20 percent while not significantly inhibiting COX-1 activity.
“Public interest in bone broth and collagen is on the rise, and many consumers use it as a supplement for joint & skin health as well as a tasty source of electrolytes,” said Stephanie Lynch, Vice President of sales, marketing, and technology. “The recent preclinical trials uncovered additional health benefits that have previously not been recognized.”
CHiKPRO® Collagen is compatible for use in FDA, USDA, and supplement products. Made from 100% USDA chicken, CHiKPRO® Collagen is free from common allergens, such as dairy, soy, as well as keto-friendly, and Certified Paleo for formulators seeking these label claims.